Galectin-3 is not predictive of cardiovascular events in patients with peripheral artery disease
Vasa
.
2021 Apr;50(3):244-245.
doi: 10.1024/0301-1526/a000940.
Epub 2021 Feb 9.
Authors
Ales Blinc
1
2
,
Mišo Šabovič
1
2
,
Juš Kšela
3
4
,
Lara Puščenik
5
,
Maja Pohar Perme
6
,
Mojca Božič Mijovski
1
5
Affiliations
1
Department of Vascular Diseases, University Medical Centre Ljubljana, Slovenia.
2
Division of Internal Medicine, Faculty of Medicine, University of Ljubljana, Slovenia.
3
Department of Cardiovascular Surgery, University Medical Centre Ljubljana, Slovenia.
4
Division of Surgery, Faculty of Medicine, University Medical Centre Ljubljana, Slovenia.
5
Faculty of Pharmacy, University of Ljubljana, Slovenia.
6
Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana, Slovenia.
PMID:
33559502
DOI:
10.1024/0301-1526/a000940
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / epidemiology
Galectin 3
Humans
Peripheral Arterial Disease* / diagnosis
Progression-Free Survival
Substances
Biomarkers
Galectin 3